Analyst Vanessa Jeffriess from Jefferies reiterated a Buy rating on Victrex (VCT – Research Report) and decreased the price target to p960.00 from p1,140.00.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Vanessa Jeffriess has given her Buy rating due to a combination of factors that suggest a positive outlook for Victrex. Despite some challenges such as the slow recovery in the Medical segment and potential tariff impacts, the company is expected to maintain its full-year guidance. This indicates confidence in its performance for the remainder of the fiscal year.
Additionally, the company’s strategic positioning and operational resilience are likely contributing to the optimistic forecast. The reaffirmation of the Buy rating, along with a new price target of 960p, reflects a belief in the company’s ability to navigate current market conditions and deliver value to shareholders.